140 related articles for article (PubMed ID: 6675797)
1. The visual system in myelin disorders.
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():1-518. PubMed ID: 6675797
[No Abstract] [Full Text] [Related]
2. Ocular manifestations in demyelinating diseases.
François J
Adv Ophthalmol; 1979; 39():1-36. PubMed ID: 532756
[No Abstract] [Full Text] [Related]
3. [Current opinions on the pathogenesis of demyelinating diseases. Part II].
Olakowska E; Pietrucha-Dutczak M; Kotulska K; Marcol W; Lewin-Kowalik J
Pol Merkur Lekarski; 2003 Nov; 15(89):480-3. PubMed ID: 14969149
[TBL] [Abstract][Full Text] [Related]
4. Demyelination in peroxisomal diseases.
Powers JM
J Neurol Sci; 2005 Feb; 228(2):206-7. PubMed ID: 15694208
[No Abstract] [Full Text] [Related]
5. The visual system in myelin disorders. A bird's eye overview.
Neetens A
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():1-39. PubMed ID: 6372921
[No Abstract] [Full Text] [Related]
6. The visual system in myelin disorders. Abnormal myelination.
Vanier T
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():105-8. PubMed ID: 6675798
[No Abstract] [Full Text] [Related]
7. Preface: white matter disorders.
Gallo V; de Vellis J
Ment Retard Dev Disabil Res Rev; 2006; 12(2):83-4. PubMed ID: 16807908
[No Abstract] [Full Text] [Related]
8. Pathology of demyelination and remyelination.
Ludwin SK
Adv Neurol; 1981; 31():123-68. PubMed ID: 7325040
[No Abstract] [Full Text] [Related]
9. [Myelin pathology in the pt rabbit].
Zelman IB; Taraszewska A
Neuropatol Pol; 1984; 22(2):205-18. PubMed ID: 6483200
[No Abstract] [Full Text] [Related]
10. Study of ocular changes in leprosy patients.
Monteiro LG; Campos WR; Oréfice F; Grossi MA
Indian J Lepr; 1998; 70(2):197-202. PubMed ID: 9724855
[TBL] [Abstract][Full Text] [Related]
11. Familial spongy degeneration of the central nervous system (Van Bogaert-Bertrand disease). An ultrastructural study.
Gambetti P; Mellman WJ; Gonatas NK
Acta Neuropathol; 1969 Jan; 12(2):103-15. PubMed ID: 5789730
[No Abstract] [Full Text] [Related]
12. A 52-year-old man with progressive left-sided weakness and white matter disease.
Fleming JO; Keegan BM; Parisi JE
Neurology; 2007 Aug; 69(6):600-6. PubMed ID: 17679680
[No Abstract] [Full Text] [Related]
13. The hypomyelinating neuropathies of mice and men.
Ouvrier RA
Rev Neurol (Paris); 1998 Jul; 154(6-7):481-7. PubMed ID: 9773081
[No Abstract] [Full Text] [Related]
14. Prospects of cell therapy for disorders of myelin.
Ben-Hur T; Goldman SA
Ann N Y Acad Sci; 2008 Oct; 1142():218-49. PubMed ID: 18990129
[TBL] [Abstract][Full Text] [Related]
15. Neuroscience: An ageing view of myelin repair.
Nave KA
Nature; 2008 Sep; 455(7212):478-9. PubMed ID: 18818646
[No Abstract] [Full Text] [Related]
16. A disturbance of late myelination as a trigger for Alzheimer's disease.
Benes FM
Neurobiol Aging; 2004 Jan; 25(1):41-3. PubMed ID: 14675729
[No Abstract] [Full Text] [Related]
17. In response to "Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies".
Caliandro P; Stålberg E; Padua L
Clin Neurophysiol; 2008 Jul; 119(7):1694-5. PubMed ID: 18467169
[No Abstract] [Full Text] [Related]
18. Ophthalmic pathobiology.
Neetens A
Bull Soc Belge Ophtalmol; 1983; 208(Pt 2):19-34. PubMed ID: 6681113
[No Abstract] [Full Text] [Related]
19. Childhood ataxia with cerebral hypomyelination (CACH) syndrome: a study of three siblings.
Vaidya SR; Desai SB; Khadilkar SV; Mehta NA
Neurol India; 2004 Sep; 52(3):372-4. PubMed ID: 15472431
[TBL] [Abstract][Full Text] [Related]
20. Myelin and disorders that affect the formation and maintenance of this sheath.
Porter BE; Tennekoon G
Ment Retard Dev Disabil Res Rev; 2000; 6(1):47-58. PubMed ID: 10899797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
